Juan (Wendy) Zhao, PhD


Research Assistant Professor

Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach


Journal article


Jacy T. Zanussi, Juan Zhao, Chad A. Dorn, Ge Liu, QiPing Feng, WeiQi Wei, Jonathan D. Mosley, C. Michael Stein, Vivian K. Kawai
Clinical Pharmacology and Therapeutics, vol. 111, 2022 Feb, pp. 435--443

Cite

Cite

APA
Zanussi, J. T., Zhao, J., Dorn, C. A., Liu, G., Feng, Q. P., Wei, W. Q., … Kawai, V. K. (2022). Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach. Clinical Pharmacology and Therapeutics, 111, 435–443.

Chicago/Turabian
Zanussi, Jacy T., Juan Zhao, Chad A. Dorn, Ge Liu, QiPing Feng, WeiQi Wei, Jonathan D. Mosley, C. Michael Stein, and Vivian K. Kawai. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics 111 (February 2022): 435–443.

MLA
Zanussi, Jacy T., et al. “Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.” Clinical Pharmacology and Therapeutics, vol. 111, Feb. 2022, pp. 435–43.


Share